FI933544A - Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel - Google Patents

Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel Download PDF

Info

Publication number
FI933544A
FI933544A FI933544A FI933544A FI933544A FI 933544 A FI933544 A FI 933544A FI 933544 A FI933544 A FI 933544A FI 933544 A FI933544 A FI 933544A FI 933544 A FI933544 A FI 933544A
Authority
FI
Finland
Prior art keywords
thiadiazinkarboxamidderivat
laekemedel
foer framstaellning
foerfaranden foer
dem
Prior art date
Application number
FI933544A
Other languages
English (en)
Other versions
FI933544A0 (fi
Inventor
Rupert Strasser
Peter Zeiller
Rainer J Klauser
Original Assignee
Luitpold Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Pharma Gmbh filed Critical Luitpold Pharma Gmbh
Publication of FI933544A publication Critical patent/FI933544A/fi
Publication of FI933544A0 publication Critical patent/FI933544A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI933544A 1991-12-13 1993-08-11 Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel FI933544A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4141218A DE4141218A1 (de) 1991-12-13 1991-12-13 Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
PCT/DE1992/001048 WO1993012119A1 (de) 1991-12-13 1992-12-11 Thiadiazincarbonsäureamidderivate, verfahren zu ihrer herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
FI933544A true FI933544A (fi) 1993-08-11
FI933544A0 FI933544A0 (fi) 1993-08-11

Family

ID=6447016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933544A FI933544A0 (fi) 1991-12-13 1993-08-11 Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel

Country Status (8)

Country Link
US (1) US5411955A (fi)
EP (1) EP0552462A1 (fi)
JP (1) JPH06506481A (fi)
AU (1) AU653663B2 (fi)
CA (1) CA2103891A1 (fi)
DE (1) DE4141218A1 (fi)
FI (1) FI933544A0 (fi)
WO (1) WO1993012119A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556909A (en) * 1994-12-02 1996-09-17 Sanofi Winthrop Inc. Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
US5750546A (en) * 1994-12-02 1998-05-12 Sanofi Winthrop, Inc. 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
US5541168A (en) * 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5494925A (en) * 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5512576A (en) * 1994-12-02 1996-04-30 Sterling Winthrop Inc. 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
WO1997024353A1 (fr) * 1995-12-28 1997-07-10 The Procter & Gamble Company 6-h-1,3,4-thiadiazine-2-amines substitues, leur utilisation en qualite d'agents anesthesiques, cardio-vasculaires et hypometaboliques, et composition pharmaceutique les contenant
ES2172606T3 (es) * 1995-12-28 2002-10-01 N T Predpr Ligand Obschestvo S 6-h-1,3,4-tiadiazin-2-aminas, su uso como agentes anestesicos, cardiovasculares e hipometabolicos, y una composicion farmaceutica que las contiene.
WO1997024354A1 (fr) * 1995-12-28 1997-07-10 The Procter & Gamble Company 6-r-1,3,4-thiadiazine-2-amines substitues, leur utilisation en qualite d'agents anesthesiques, cardio-vasculaires et hypometaboliques, et composition pharmaceutique les contenant
GT200000203A (es) 1999-12-01 2002-05-24 Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas.
KR100426179B1 (ko) * 2000-05-10 2004-04-03 주식회사 엘지생명과학 N-(α-시아노-2-테닐)-4-에틸-2-(에틸아미노)-5-티아졸카르복사미드를 함유하는 신규한 살균제 조성물
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US20230131668A1 (en) * 2020-02-14 2023-04-27 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Heat shock protein modulators and anti-huntington disease therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956997A (en) * 1957-04-04 1960-10-18 Geigy Chem Corp Substituted 3, 5-dioxo-tetrahydro-1, 2, 6-thiadiazine-1, 1-dioxides
US3203954A (en) * 1963-07-15 1965-08-31 Upjohn Co Novel 3, 5-disubstituted-1, 2, 6-(2h)-thiadiazine-1, 1-dioxides
US3223703A (en) * 1963-08-01 1965-12-14 Upjohn Co 3-carbalkoxy- and 3-carbamoyl-5-subtituted - (2h) - 1,2,6 - thiadiazine - 1,1-dioxides and process
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4450269A (en) * 1977-03-30 1984-05-22 Fmc Corporation Mono-5-substituted-3-chloro-4H-1,2,6-thiadiazin-4-one antifungal agents
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives

Also Published As

Publication number Publication date
CA2103891A1 (en) 1993-06-14
WO1993012119A1 (de) 1993-06-24
JPH06506481A (ja) 1994-07-21
AU653663B2 (en) 1994-10-06
DE4141218A1 (de) 1993-06-17
FI933544A0 (fi) 1993-08-11
AU3081092A (en) 1993-07-19
US5411955A (en) 1995-05-02
EP0552462A1 (de) 1993-07-28

Similar Documents

Publication Publication Date Title
FI923558A (fi) Tetrahydroindazol-, tetrahydrocyklopentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas
FI914611A (fi) 2-aminopyrimidin-4 -karboxamidderivat, framstaellning och terapeutisk anvaendning av dem.
FI931291A (fi) Indol- och indazolderivat foer behandling och foerebyggande av hjaernsjukdomar, deras framstaellning och anvaendning
FI913723A0 (fi) Dihydroxipropylsulfoetylcellulosor, framstaellning och anvaendning av dem.
FI933544A (fi) Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel
FI922867A0 (fi) Dikarbonsyraderivat och foerfarande foer framstaellning av dem.
FI935829A0 (fi) Anlaeggning och foerfarande foer uttnyttjning av braennbara aemnen, speciellt industri- och hushaollsavfall
FI922168A0 (fi) Foerfarande och anordning foer ultrasonisk provning av kaernkraftbraensleelement under anvaendning av en passtyrning.
FI922139A0 (fi) Foerfarande och anordning foer framstaellning av anhydrit-stykgips.
FI921814A (fi) 2-aminopyrimidin-4-karboxiamidderivat, deras framstaellning och terapeutisk anvaendning av dem
FI923204A0 (fi) Nedbrytbara karbonylhaltiga kelateringsmedel, anvaendning av dessa och kompositioner.
FI931527A0 (fi) Foerfarande foer behandling av avfall fraon katodstraolroer, speciellt bildroer, respektive glasdelar av dem
FI925974A0 (fi) Humant rotavirus-hcr3, nyorganiserade stammar av detta och vaccinkompositioner innehaollande dessa
FI924281A (fi) Tienocyklopentanonoximers etrar, deras framstaellning och farmaceutiskasammansaettningar innehaollande dem
FI915281A (fi) Expanderbara och expanderade partiklar och foerfarande foer framstaellning av dem.
FI935170A (fi) Nya kiralsulfater, framstaellning av dem och anvaendning i syntesen av farmaceutiska foereningar
FI923549A0 (fi) Heterocykliska karboxylestrar, foerfarande foer framstaellning av dem och anvaendningen av dem vid framstaellning av gastrointestinala laekemedel.
FI910732A0 (fi) Foerfarande och anordning foer foerverkling av en regenerativ svavelbindning.
FI922171A (fi) Fordon foer lastning, kompaktering och avlaemning av avfall
FI914349A (fi) Betonggjutform, foerfarande foer foerbindning av betonggjutformdelar tillvarandra och foerbindningsstycke
FI716U1 (fi) Anordning foer stoedande och fasthaollande av traestycken, foerdelaktigen under uppskaerning till braeder
FI881318A (fi) Transportbehaollare foer olika vaetskor och foerfarande foer utnyttjande av dem.
FI932408A0 (fi) Foerfarande foer foeraendring av deinkade returpappersmassors egenskaper, saerskilt fiberfraktion, och maskinsats foer genomfoerande av detta foerfarande
FI924974A0 (fi) Foerfarande och anordning foer framstaellning av nytt, foer massaindustrius bruk avsett fibermaterial av vanligt stock- och fiberraomaterial
FI910085A (fi) Foerfarande och anordning foer tillvaratagande av freoner.

Legal Events

Date Code Title Description
FD Application lapsed